Compare Quest Diagnostics Inc (DGX) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Pinterest Inc — how do they compare? Quest Diagnostics Inc trades at $229.97 (market cap $25.48B), while Pinterest Inc trades at $21.31 (market cap $11.63B). The key difference: Quest Diagnostics Inc is far larger — about 2.2× Pinterest Inc's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while Pinterest Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Pinterest Inc for 85 Days on average.
| DGX | PINS | |
|---|---|---|
Market Cap | $25.48B | $11.63B |
Volume | 941,866 | 12,792,940 |
Sector | Health | Media |
52-Week High | $247.45 | $35.24 |
52-Week Low | $173.49 | $15.42 |
Typical Hold Time | 56 Days | 85 Days |
Enterprise Value | $31.23B | $11.55B |
Dividend Yield | 1.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.97, up 1.75% today, with a technical bias leaning bearish despite recent earnings beats. Revenue grew to $11.04B in 2025, with net income reaching $992M, though profit margins have moderated. Analyst consensus is a $250 price target with a mixed buy/hold sentiment. Recent news highlights growth in consumer testing and partnerships, alongside concerns over potential Medicare reimbursement cuts.
The outlook balances solid fundamentals and growth initiatives against regulatory risks. Upside potential exists from continued operational execution and new ventures like the Apple Health app integration, but investors face headwinds from reimbursement uncertainty and a high debt load. The stock's valuation appears reasonable relative to peers, supporting a cautious but opportunistic view.
Pinterest (PINS) trades at $21.40, up 5.37% with bullish technical signals despite mixed oscillators. The company shows strong revenue growth from $2.8B in 2022 to $4.2B in 2025, with recent earnings beats and a 79.5% gross margin. Analyst consensus is bullish with a $27.93 price target, though high P/E of 60.4 and insider selling pose valuation concerns.
Outlook remains positive driven by international monetization and new ad products, but risks include competitive pressure and reliance on advertising revenue. The stock offers growth potential if execution continues, though current valuation demands careful monitoring of earnings sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
